REN and hypertensive disorder: Hypertensive patients in these two studies all shared certain similarities including near-universal low or undetectable plasma renin activity (PRA), presentation of high blood pressure around 35–40 weeks postmenstrual age (PMA), and an excellent response to treatment with spironolactone.